VEGFA and early-onset autosomal dominant Alzheimer disease: For example, in diseases such as Parkinson’s disease [71], Alzheimer’s disease [72], or Amyotrophic lateral sclerosis (ALS) [73], there is hope that VEGF-based therapy can help to improve treatment.